Brady Todd C

Average Profitability
8.55%
Insider Buys Quantity
12
Insider Buys Sum
$1.54M
Insider Sells Quantity
2
Insider Sells Sum
$580,759.68

Insider Activity of Brady Todd C

According to the SEC Form 4 filings, Brady Todd C, being in a position of

  1. President and CEO at Aldeyra Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 183238 shares for $580,760,
    over all time since 2014-05-07, has bought 273596 shares for $1.5M, and sold 183238 shares for $580,760.

The largest purchase of all time was on 2019-09-13 and amounted to 37094 shares of Aldeyra Therapeutics, Inc. for $218,717.

The largest sale of all time was on 2024-03-11 and amounted to 97914 shares of Aldeyra Therapeutics, Inc. for $320,521.

Biography of Brady Todd C

No biography is available at this moment.

2024-03-12SaleAldeyra Therapeutics, Inc.
ALDX
President and CEO
85,324
0.147%
$3.05$260,238+38.54%
2024-03-11SaleAldeyra Therapeutics, Inc.
ALDX
President and CEO
97,914
0.1675%
$3.27$320,521+28.15%
2022-06-23PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
17,700
0.0284%
$3.36$59,546+81.06%
2019-12-16PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
40,000
0.1376%
$5.10$203,816+15.38%
2019-09-30PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
17,420
0.0643%
$5.68$98,967+2.28%
2019-09-23PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
17,360
0.0627%
$5.81$100,865-9.61%
2019-09-18PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
28,576
0.1084%
$5.91$168,930-6.78%
2019-09-16PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
6,000
0.0228%
$6.03$36,180-8.38%
2019-09-13PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
37,094
0.1401%
$5.90$218,717-6.94%
2019-09-10PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
20,000
0.0713%
$5.39$107,874-3.94%
2019-09-09PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
20,000
0.0774%
$5.14$102,824+9.39%
2017-02-17PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
44,446
0.2842%
$4.50$200,007+0.98%
2014-09-23PurchaseEvoke Pharma, Inc.
EVOK
director
8,000
0.1364%
$5.70$45,603+0.78%
2014-05-07PurchaseAldeyra Therapeutics, Inc.
ALDX
President and CEO
25,000
0.8844%
$8.00$200,000+20.66%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.